Stock Events

Stock Events

Y mAbs Therapeutics (YMAB) Q2 2025 Earnings

13MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.21

-0.18

-0.15

-0.12

Details

Expected EPS

-0.212222

Actual EPS

-0.12

Surprise EPS

0.09

Surprise Percent

+43.46%

Description

Y mAbs Therapeutics (YMAB) has reported earnings of -0.12 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.